US$1.40m (loss narrowed by 71% from 2Q 2024). US$0.007 loss per share (improved from US$0.031 loss in 2Q 2024). AI is about ...

The drug maker reports second-quarter earnings Tuesday, and investors continue to eye a list of glaring problems.

Pfizer ( PFE) reported a beat in second quarter earnings Tuesday, and reaffirmed its 2025 guidance of between $61 to $64 ...

Over the last five years, the stock has decreased in 56% of these instances, with a median decline of -3.1% and a maximum ...

This would indicate a 29% rise in earnings compared to the previous year and a 6% increase in sales when compared to last ...

According to a regulatory filing late Monday, Berkshire Hathaway sold approximately 1.64 million shares of DaVita Inc. on ...

Palantir recently secured a major victory with the U.S. Army's new Enterprise Agreement that establishes a comprehensive ...

Q2 2025 Management View Paul Richards, EVP and CFO, reported "For the second quarter, we reported a net income of $0.54 per ...

The best place to start is to determine how the stock is valued, and one of the most popular and effective metrics to help make that judgment is earnings per share, known as EPS. "We use a wide ...

Management described loan origination targets as repayment-dependent, acknowledging portfolio growth and dividend stability could be at risk if anticipated repayments do not materialize as projected, ...

Nifty 50 EPS projected to grow by 10% in FY26, supported by fiscal measures and sectoral preferences, per Motilal Oswal.

On a per-share basis, the Boise, Idaho-based company said it had net income of $1.76. The results met Wall Street ...